TRUEMAB Trademark
TRUEMAB is a USPTO trademark filed by Origene Technologies, Inc.. Status: Registered.
Prosecution Summary
Trademark Summary
The mark TRUEMAB features the wording with a design of an antibody and covers monoclonal antibodies for in vitro scientific or research use in International Class 001. It is owned by Origene Technologies, Inc., a Delaware corporation based in Rockville, Maryland. The mark is registered on the Principal Register since July 3, 2012, and was renewed for a first 10-year term on December 30, 2021, with Sections 8 and 9 accepted; class 001 remains active, while other classes (005, 006, 010, 026, 046) are listed but lack detailed descriptions.
Recent Activity
Filed on December 21, 2010, the application overcame office actions including a final refusal before publication on April 17, 2012, and registration on July 3, 2012. Most recently, on December 3
Trademark Facts
| Mark | TRUEMAB |
|---|---|
| Serial Number | 85203359 |
| Registration Number | 4166501 |
| Status | Registered |
| Filing Date | 2010-12-21 |
| Registration Date | 2012-07-03 |
| Mark Type | Combined |
| Nice Classes | 001 (Chemicals) |
| Owner | Origene Technologies, Inc. |
| Attorney of Record | Jeffrey R. Cohen |
| Prosecution Events | 41 |
| Latest Event | NA89 on 2021-12-30 |
Goods & Services
monoclonal antibodies for in vitro scientific or research use